Which factors should be taken into account in perimenopausal women with early breast cancer who may become eligible for an aromatase inhibitor? Recommendations of an expert panel
O. Ortmann, O. Pagani, A. Jones, N. Maass, D. Noss, H. Rugo, C. van de Velde, Matti Aapro, R. ColemanVolume:
37
Year:
2011
Language:
english
Pages:
105
DOI:
10.1016/j.ctrv.2010.05.005
File:
PDF, 273 KB
english, 2011